2Gibson CM, Schmig A. Coronary and myocardial anglography:angiographic assessment of both epicardial and myocardial perfusion [ J ]. Circulation, 2004,109:3096. 被引量：1
3Kloner RA, Ganote CE, Jennings RB. The no - reflow phenomenon after temporary coronary occlusion in the dog[ J]. J Clin Invest, 1974,54 : 1496. 被引量：1
4Schofer J, Monta R,Maflley D. Scintigraphic evidence of the no - reflow'phenomenon in human beings after coronary thrombolysis[J]. J Am Coll Cardiol, 1985,5:593. 被引量：1
5ates ER,Krell M J, Dean EN,et al. Demanstrast ion of the' no - reflow'phenomenon by digital coronary arterlography [ J ]. Am J Cardiol, 1986,57 : 177. 被引量：1
6Eeckhout E, Kern MJ. The coronary no - reflow phenomenon: a review of mechanisms and therapies [ J ]. European Heart Journal ,2001,22:729. 被引量：1
7Reffelmann T, Kloner RA. Microvascular reperfusion injury: Rapid expansion of anatomic no reflow during reperfusion in the rabbit [J]. Am J Physiol,2002,283 : H 1099. 被引量：1
1[12]Antoniucci D,Migliorini A,Parodi G,et al.Abciximab-supported infarct artery stent imp-lantation for acute myocardial infarction and long-term survival:a prospective,multicenter,randomized trial comparing infarct artery stenting plus abciximab with stenting alone.Circulation,2004,109:1704-1706. 被引量：1
2[13]Kern MJ,Aguirre F,Bach R,et al.Augmentation of coronary blood flow by inra-aortic balloon pumping in patients after coronary angiop lasty.Circulation,1993,87:500-511. 被引量：1
3[14]Sutsch G,Kiowski W,Bossard A,et al.Use of an emboli containment and retrieval system during percutaneous coronary angiop lasty in native coronary arteries.J Invasive Cardiol,2002,14:C64-C72. 被引量：1
4[1]Tanaka A,Kawarabayashi T,Nishibori Y,et al.No-reflow phenomenon and lesion mophology in patients with acute myocardial infarction.Circulation,2002,105:2148-2152. 被引量：1
5[2]Jones CJ H,DeFily DV,Pat terson JL,et al.Endot helium-dependent relaxation competes with α1-and α2-adrenergic constriction in the canine epicardial coronary microcirculation.Circulation,1993,87:1264. 被引量：1
6[3]Golino P,Ragni M,Cirillo P,et al.Recombinant human,active site blocked factor Ⅶ reduces infarct size and no-reflow phenomenon in atherosclerotic vascular disease.Circulation,2000,278:1507-1516. 被引量：1
7[4]Baim D.On behalf of the SAFER investigators:transcatheter cardio-vascular therapeutics meeting.Washington DC,2000,October. 被引量：1
8[5]Engler RL,Dahlgren MD,Morris DD,et al.Role of leukocytes in response to acute myocardial ischemia and reflow in dogs.Am J Physiol,1986,251:1131-1132. 被引量：1
9[6]Michaels AD,Appleby M,Otten MH,et al.Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions:results of the randomized,controlled vasodilator prevention on no-rellow (VAPOR) trial.J Invasive Cardiol,2002,14:299-302. 被引量：1
10[7]Desmet WJ,Dens J,Coussement P,et al.Does adenosine prevent myocardial micronecrosis following precutaneous coronary intervention? ADELINE pilot trial.ADEnosine Limit myocardial Necrosis.Heart,2002,88:293-295. 被引量：1
